Mike Wort, Managing Director

Mike Wort is Managing Director of De Facto Communications and Bell Pottinger Health’s Head of Financial Communications. He specialises in both life sciences communications and in healthcare financial communications. A trained microbiologist, he has worked in a number of senior sales, marketing and technical roles for Glaxo, SmithKline and Wellcome in the UK and overseas.

An expert in financial communications, Mike has managed more than 10 IPOs raising well in excess of £200 million, worked on secondary and follow-on offerings raising in excess of £2.4 billion, consulted on a number of mergers and acquisitions of products and companies in the life science sector, developed disaster recovery programmes for SME companies, and conducted due diligence on products companies and facilities for acquisition purposes.

Mike also worked with Deutsche Bank to raise money to privatise the Bulgarian pharmaceutical industry. As the CEO of Balkanpharma, he led the consolidation of the three pharmaceutical facilities in Bulgaria into one cohesive organisation. Balkanpharma remains the core of the Actavis Group the US$ 1.4 billion market capitalization generics manufacturing company.